Join
Live feed
·
PRReleasevia Quantisnow
Synlogic Inc. logo

Synlogic Announces Positive Phase 2 Data Demonstrating Reduction in Plasma Phenylalanine Levels in Patients with Phenylketonuria

ByQuantisnow·Wall Street's wire, on your screen.
SYBX· Synlogic Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track SYBX (Synlogic Inc.) and more on Quantisnow.